Home Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward
 

Keywords :   


Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward

2015-11-14 12:16:55| Biotech - Topix.net

Alnylam has had a summer of discontent as worries about the efficacy and tolerability of a lead drug combine with broader concerns about drug pricing and biotech valuations. Even if revusiran is inferior to Isis's rival compound, a backup compound could more than make up the difference and Alnylam is making broad overall progress with its pipeline.

Tags: multiple forward programs moving

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »